These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9228976)

  • 21. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott PM
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract]   [Full Text] [Related]  

  • 22. Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy.
    Elliott P; Gimeno J; Tomé M; McKenna W
    Eur Heart J; 2006 Dec; 27(24):3073; author reply 3073-4. PubMed ID: 17121751
    [No Abstract]   [Full Text] [Related]  

  • 23. Investigation and treatment of hypertrophic cardiomyopathy.
    Elliott P
    Clin Med (Lond); 2007 Aug; 7(4):383-7. PubMed ID: 17882858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertrophic cardiomyopathy and outflow tract obstruction.
    Spevack DM
    N Engl J Med; 2003 May; 348(18):1815-6; author reply 1815-6. PubMed ID: 12728916
    [No Abstract]   [Full Text] [Related]  

  • 25. Sudden death and hypertrophic cardiomyopathy.
    Spirito P; Maron BJ
    Lancet; 2001 Jun; 357(9272):1975-6. PubMed ID: 11430387
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypertrophic cardiomyopathy in childhood.
    Maron BJ
    Pediatr Clin North Am; 2004 Oct; 51(5):1305-46. PubMed ID: 15331286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy.
    Maron BJ; Haas TS; Lesser JR
    Circulation; 2007 Jun; 115(24):e627-8. PubMed ID: 17576874
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictors of death from congestive heart failure in hypertrophic cardiomyopathy.
    Ikeda H; Maki S; Yoshida N; Murohara T; Adachi H; Koga Y; Imaizumi T
    Am J Cardiol; 1999 Apr; 83(8):1280-3, A9. PubMed ID: 10215301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten common questions about hypertrophic cardiomyopathy...and misconceptions.
    Maron BJ
    Cardiol Rev; 2005; 13(2):59-60. PubMed ID: 15705254
    [No Abstract]   [Full Text] [Related]  

  • 31. Torsades de pointes in a case of hypertrophic cardiomyopathy with special reference to the pathologic findings of the heart including the conduction system.
    Kuboki K; Ohkawa S; Chida K; Watanabe C; Ueda K; Sugiura M
    Jpn Heart J; 1999 Mar; 40(2):233-8. PubMed ID: 10420884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophic cardiomyopathy.
    Subasic K
    Nurs Clin North Am; 2013 Dec; 48(4):571-84. PubMed ID: 24295188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 34. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
    Maron BJ; Olivotto I; Maron MS
    Eur Heart J; 2006 Aug; 27(16):1895-7. PubMed ID: 16818455
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypertrophic cardiomyopathy.
    Ommen SR
    Curr Probl Cardiol; 2011 Nov; 36(11):409-53. PubMed ID: 21962729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
    Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
    Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden cardiac death from hypertrophic cardiomyopathy and acute idiopathic (Fiedler's) myocarditis: autopsy report.
    Takata Y; Teraoka K; Abe M; Ogawa T; Inuzuka H; Ochiai T; Abe T; Kusama H; Shimada H; Ibukiyama C
    Intern Med; 1993 Oct; 32(10):815-9. PubMed ID: 8012080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The never ending story of risk stratification for sudden death in hypertrophic cardiomyopathy.
    Christiaans I; Wilde AA
    Am J Cardiol; 2011 Jun; 107(12):1871. PubMed ID: 21640227
    [No Abstract]   [Full Text] [Related]  

  • 39. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.
    Furushima H; Chinushi M; Iijima K; Sanada A; Izumi D; Hosaka Y; Aizawa Y
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):991-9. PubMed ID: 20487113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypertrophic cardiomyopathy in 2013].
    Giannakopoulos G; Frangos C
    Rev Med Suisse; 2013 Mar; 9(376):502, 504-7. PubMed ID: 23534110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.